Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00218335 · ClinicalTrials.gov registry record · Phase 2
A Network & Dyad HIV Prevention Intervention for IDU's - 1
A Phase 2 study, sponsored by Johns Hopkins Bloomberg School of Public Health.
- Completed
- Registry status
- Phase 2
- Development phase
- 1,024
- Enrollment target
NCT00218335 is a Phase 2 study that has completed, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 1,024 participants.
The verdict
NCT00218335, a Phase 2 study, has completed, sponsored by Johns Hopkins Bloomberg School of Public Health.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 1,024 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate a peer-based HIV prevention intervention that targets active injection drug users and their drug and sex partners.
Interventions
- BEHAVIORAL Control Condition
- BEHAVIORAL Intervention Condition
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,024 participants |
| Start Date | 2003-06 |
| Est. Completion | 2008-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00218335
The ClinicalTrials.gov registry entry for NCT00218335 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 1,024 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins Bloomberg School of Public Health, which has 187 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control Condition is the first listed.
NCT00218335 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00218335 about?
NCT00218335 is a clinical study titled "A Network & Dyad HIV Prevention Intervention for IDU's - 1". The purpose of this study is to evaluate a peer-based HIV prevention intervention that targets active injection drug users and their drug and sex partners.
What is the current status of trial NCT00218335?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 1,024 participants. The study started on 2003-06. Estimated completion is 2008-05.
What interventions are being tested in trial NCT00218335?
The interventions under investigation include: Control Condition (BEHAVIORAL), Intervention Condition (BEHAVIORAL).
Who is sponsoring clinical trial NCT00218335?
This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.